NCT00396565 - A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia | Biotech Hunter

Enrollment

394

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Schizophrenia

Interventions

DRUG

ER OROS paliperidone

Type= exact number, unit= mg, number= 3, form= tablet, route= oral use. Two tablets once daily for 6 weeks.

DRUG

Placebo

Form= tablet, route= oral use. Two tablets once daily for 6 weeks.

DRUG

Olanzapine

Type= exact number, unit= mg, number= 2.5, form= tablet, route= oral use. Four tablets once daily for 6 weeks.

Trial Locations (56)

Unknown

Aizu-Wakamatsu

Fujioka

Fujisawa

Fukui

Hadano

Himeji

Hiratsuka

Hiroshima

Ibaraki

Ichikawa

Iida

Inazawa

Itoman

Kaizuka

Kanzaki

Kashihara

Kitakyushu

Kochi

Kōshi

Kumamoto

Kurayoshi

Matsudo

Matsusaka

Moriguchi

Morioka

Nagoya

Naha

Nakagami

Nankoku

Nishinomiya

Noda

Numazu

Ohta

Okinawa

Oyama

Ōita

Sakai

Sapporo

Takasaki

Takatsuki

Tanba

Tokyo

Tottori

Toyama

Toyoake

Toyonaka

Tōgane

Tsuyama

Ueda

Urasoe

Uruma

Yanagawa

Yao

Yokkaichi

Yokohama

Yokosuka